髂动脉慢性完全闭塞顺行与逆行开通策略的急性和中期结局
最终顺行开通与较低的靶病变并发症风险相关(OR 0.07,95%CI 0.01-0.81,P=0.034),但两种策略的病变成功率、靶病变血运重建和主要不良肢体事件相似。
要点
- 最终顺行开通与较低的靶病变并发症风险独立相关。
- 顺行与逆行策略的病变成功率和1年、3年靶病变血运重建及主要不良肢体事件相似。
- 外部髂动脉慢性完全闭塞更常首选顺行开通,且无论方向如何首次尝试成功率最高。
核心结论
- 最终顺行开通策略与较低的靶病变并发症风险相关,但两种策略在病变成功率、靶病变血运重建和主要不良肢体事件方面相似。
主要发现
- 髂外动脉慢性完全闭塞更常首选顺行策略(p<0.005),髂总动脉(p<0.005)和髂总/髂外联合病变(p<0.005)更常首选逆行策略。
- 初始顺行尝试中27.6%需转换策略,初始逆行尝试中9.6%需转换策略。
- 最终逆行开通的病变较短(75.3±34.9 vs 87.6±31.3 mm,p=0.005),更常使用再入装置(34.2% vs 9.2%,p<0.001)和球囊扩张支架(39.2% vs 17.7%,p=0.005)。
- 最终顺行开通与较低的靶病变并发症风险相关(OR 0.07,95%CI 0.01-0.81,p=0.034)。
- 两种开通策略的1年和3年靶病变血运重建及主要不良肢体事件估计值相似。
关键数值与推荐
- 最终逆行开通123处(65.4%)病变,最终顺行开通65处病变,两组总体靶病变成功率分别为95.1%和93.2%(p=0.456)。
- 髂外动脉慢性完全闭塞最可能通过初始尝试(无论策略)成功开通。
临床怎么用
- 对于髂动脉慢性完全闭塞,顺行和逆行开通策略均可实现较高的病变成功率,临床可根据病变特征选择。
- 当优先考虑降低靶病变并发症风险时,最终顺行开通可能更有利。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To examine whether an antegrade or retrograde crossing strategy for treatment of iliac artery chronic total occlusions (CTOs) is associated with differences in procedural or midterm outcomes. MATERIALS AND METHODS: A dual-center retrospective cohort study was conducted in 168 patients (mean age 66.4±10.6 years; 116 men) treated for CTOs in 110 common iliac arteries (CIA), 52 external iliac arteries (EIA), and 26 combined CIA/EIAs. Logistic regression models were developed to determine the association between crossing strategy and procedural complications, 1- and 3-year target lesion revascularization (TLR), and major adverse limb events (MALE). Results are presented as the odds ratio (OR) and 95% confidence interval (CI). RESULTS: An initial antegrade strategy was more common for EIA CTOs (p<0.005), and an initial retrograde strategy was more often used in CIA (p<0.005) and combined CIA/EIA (p<0.005) CTOs. Crossover to an alternate approach was required in 27.6% of initial antegrade attempts and 9.6% of initial retrograde attempts. EIA CTOs were the most likely lesions to be treated successfully with the initial attempt (either strategy). In all, 123 (65.4%) lesions were successfully crossed with a final retrograde approach and 65 with a final antegrade approach. Overall target lesion success was high for both groups (95.1% vs 93.2%, p=0.456). Lesions treated with a final retrograde approach were shorter (75.3±34.9 vs 87.6±31.3 mm, p=0.005) and were more likely to be treated with a reentry device (34.2% vs 9.2%, p<0.001) and with balloon-expandable stents (39.2% vs 17.7%, p=0.005). The final antegrade approach was associated with a lower risk of target lesion complications (OR 0.07, 95% CI 0.01 to 0.81, p=0.034). The two crossing approaches were associated with similar estimates of 1- and 3-year TLR and MALE. CONCLUSION: A final antegrade approach was associated with lower rates for complications but the 2 approaches were similar in terms of lesion success, TLR, and MALE. The EIA CTOs were more likely to be treated with an antegrade approach and more likely to be crossed successfully with the initial approach irrespective of the crossing direction.
引用
- Kokkinidis DG, Foley TR, Cotter R, et al. Acute and Midterm Outcomes of Antegrade vs Retrograde Crossing Strategies for Endovascular Treatment of Iliac Artery Chronic Total Occlusions. J Endovasc Ther. 2019. PMID: 31106693. doi:10.1177/1526602819845679
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。